The treatment of Bone Health & Hepatitis C with vitamins

Bone Health and Hepatitis C: Mitamins custom make quality formulas for the treatment of Bone Health & Hepatitis C with vitamins. A Bone Health & Hepatitis C formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Bone Health and Hepatitis C

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin D
    200
    IU
    50%
    Vitamin E
    100
    IU
    333%
    Calcium
    200
    mg
    20%
    Magnesium
    100
    mg
    25%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    Choline Bitartrate
    50
    mg
    *
  • Amount Per Serving
    % DV
    Inositol
    50
    mg
    *
    Alpha Lipoic Acid
    50
    mg
    *
    Boron
    1000
    mcg
    *
    Silicon
    2
    mg
    *
    Milk Thistle Extract
    50
    mg
    *
    L-Methionine
    100
    mg
    *
    Dandelion Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Bone Health and Hepatitis C Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Rocket-Powered Mechanical Arm Could Revolutionize Prosthetics
Combine a mechanical arm with a miniature rocket motor: The result is a prosthetic device that is the closest thing yet to a bionic arm. A prototype of this radical design has been successfully developed and tested by a team of mechanical engineers at Vanderbilt University as part of a $30 million federal program to develop advanced prosthetic devices.
InterMune Announces Start Of Phase 1b Trial Of ITMN-191
InterMune, Inc. (Nasdaq: ITMN) announced that the company has begun dosing the first patients in their Phase 1b multiple ascending dose (MAD) clinical trial evaluating ITMN-191 (also called R7227) in patients with chronic hepatitis C. ITMN-191 is a hepatitis C virus (HCV) protease inhibitor in development by InterMune and its partner, Roche. InterMune also reported additional information from its recently completed Phase 1a clinical trial of ITMN-191.
This information concerning the support of Bone Health and Hepatitis C treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments